טוען...
SEVERE INSULIN RESISTANCE WITH DIABETIC KETOACIDOSIS AFTER BRENTUXIMAB TREATMENT
OBJECTIVE: To increase awareness of unusual inflammatory and other responses including severe insulin resistance (IR) associated with the use of targeted immunotherapies such as brentuximab. METHODS: We report the case of a man without any previous diagnosis of diabetes who developed diabetic ketoac...
שמור ב:
| הוצא לאור ב: | AACE Clin Case Rep |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Association of Clinical Endocrinologists
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7282153/ https://ncbi.nlm.nih.gov/pubmed/32524020 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4158/ACCR-2019-0435 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|